2015年-2025年树兰医疗集团脂肪肝专病库数据集

该数据为2015年至2025年期间树兰医疗集团旗下5家医院在对脂肪肝患者提供诊疗过程中产生，数据包含匿名化处理后的门诊诊断数据、门诊影像检查数据、检验结果数据等关键维度。树兰医疗集团可以通过处理这些数据，为医院提供诊断依据、提高诊断准确率、优化疾病用药、提升医院运营效率。数据可支撑监测患者肝代谢指标、智能风险预警与分层管理、个性化干预方案生成、脂肪肝发病趋势预测与科研分析等功能，能够用于预测脂肪肝患者病情变化、预测个体发病风险，助力早期干预，缓解临床诊疗压力。在当下脂肪肝发病率逐年攀升、病因复杂且易引发多种并发症的背景下，提升集团在脂肪肝精准医疗和健康管理领域的竞争力。

This dataset was collected during the diagnosis and treatment of fatty liver patients at 5 hospitals affiliated with Treelex Medical Group between 2015 and 2025. It includes key dimensions such as anonymized outpatient diagnosis data, outpatient imaging examination data, and laboratory test results. Treelex Medical Group can leverage these processed data to provide diagnostic support for hospitals, improve diagnostic accuracy, optimize disease medication regimens, and enhance hospital operational efficiency. This dataset enables functions including monitoring patients' liver metabolic indicators, intelligent risk early warning and stratified management, generation of personalized intervention plans, prediction of fatty liver incidence trends, and scientific research analysis. It can be utilized to predict disease progression in fatty liver patients and individual disease onset risk, facilitate early clinical intervention, and alleviate pressure in clinical diagnosis and treatment. Against the backdrop of the rising annual incidence of fatty liver, complex etiology and high susceptibility to multiple complications, this dataset helps enhance the Group's competitiveness in the fields of precise fatty liver medicine and health management.

搜集汇总

背景与挑战

背景概述

该数据集包含树兰医疗集团2015-2025年脂肪肝患者的匿名诊疗数据，支持病情预测、风险预警和个性化干预，旨在提升脂肪肝精准医疗和健康管理能力。